Vical Presents Pandemic Influenza Vaccine Results, Outlook at WHO Meeting

Vical Incorporated presented to the world’s leading pandemic influenza vaccine experts a summary of complete results from the company’s successful Phase 1 trial and future goals for its pandemic influenza DNA vaccine program.
TradingMarkets